Effectiveness of Pumpkin Seed Extract on Improving Blood Sugar Level in Subhealth Subjects

Launched by GREENYN BIOTECHNOLOGY CO., LTD. · Feb 12, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how effective pumpkin seed extract can be in helping people manage their blood sugar levels. It specifically targets individuals who may not yet have diabetes but have higher-than-normal blood sugar levels, a condition known as subhealth. The study is currently recruiting participants, and people of all ages are welcome to join, as long as they meet certain health criteria.

To be eligible for the trial, participants should have fasting blood sugar levels between 100 and 125 mg/dL, which indicates they could be at risk for diabetes. However, individuals who are pregnant, breastfeeding, or have certain health issues—such as severe kidney problems or chronic diseases—are not eligible. Those who join the study will receive either the pumpkin seed extract or a placebo (a dummy treatment) to see how it affects their blood sugar levels over time. It’s a chance to contribute to research that could benefit many people in managing their health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Fasting blood sugar levels from 100 to 125 mg/dL
• • Glycated hemoglobin levels from 5.7 to 6.4%
• • 2-hour OGTT levels from 140 to 199 mg/dL
• Exclusion Criteria:
• • Pregnant women or preparing for pregnancy.
• • Lactating women.
• • Women gave birth 6 months before the study.
• • Poor kindy funciton
• • Severe cardiovascular or other chronic diseases
• • Patients with type I or II diabetes
• • Poor compliance
• • Alcohol abuser
• • Using anti-diabetic or weight managent supplements
• • Blood transfusion three months before the study
• • Pumpkin seed allergy